News

The AI Journal
aijourn. com > days-after-launch-attunio-health-expands-precision-psychiatry-infrastructure-with-quest-diagnostics-and-getlabs

Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs

22+ hour, 47+ min ago  (360+ words) ATLANTA, June 25, 2026 /PRNewswire/ " Just days after publicly launching its AI-powered precision psychiatry platform and gaining early media attention, Attunio Health announced a major expansion of its clinical infrastructure by selecting Quest Diagnostics as its national laboratory backbone and integrating Getlabs…...

Symbols: btc-usd
The AI Journal
aijourn. com > datacc-by-dime-releases-first-set-of-digital-measures-built-specifically-for-common-mental-health-disorders

DATAcc by Di Me releases first set of digital measures built specifically for common mental health disorders

3+ week, 1+ day ago  (193+ words) Developed with 20+ partners across industry, advocacy, and research, the resources give drug developers, regulators, payors, and clinicians a shared foundation for measuring symptoms and treatment effects BOSTON, June 4, 2026 /PRNewswire/ "The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine…...

Symbols: nasdaq:dftx,nasdaq:nrxp
The AI Journal
aijourn. com > alto-neuroscience-highlights-invited-review-in-american-journal-of-psychiatry-establishing-neuroplasticity-as-a-core-driver-of-psychiatric-disease-and-treatment

Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment

4+ mon, 3+ week ago  (134+ words) " The review provides strong scientific rationale to support Alto's drug development approach leveraging its Precision Psychiatry Platform " The authors further highlight a critical industry gap: the historical absence of translatable biomarkers that directly index plasticity changes in humans. Addressing this…...

Symbols: ocd,nyse:anro,who